(Q38009999)

26 August 2017

title

Pleural effusion in lung cancer: more questions than answers (English)

1 reference

26 August 2017

1 reference

Marios E Froudarakis

1

1 reference

26 August 2017

publication date

7 May 2012

1 reference

26 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Respiration

1 reference

26 August 2017

volume

83

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

367-376

1 reference

Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient

26 August 2017

cites work

1 reference

The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients

21 January 2018

1 reference

Diagnostic work-up of pleural effusions

21 January 2018

1 reference

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience

21 January 2018

1 reference

The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung ca

21 January 2018

1 reference

Diagnostic molecular biomarkers for malignant pleural effusions.

21 January 2018

1 reference

Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene

21 January 2018

1 reference

Epidermal growth factor regulates the expression of its own receptor

21 January 2018

1 reference

The biology of epidermal growth factor receptor in lung cancer

21 January 2018

1 reference

The role of gefitinib in lung cancer treatment.

21 January 2018

1 reference

Weighing tumor biology in treatment decisions for patients with non-small cell lung cancer

21 January 2018

1 reference

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan

21 January 2018

1 reference

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

21 January 2018

1 reference

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

21 January 2018

1 reference

Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer

21 January 2018

1 reference

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.

21 January 2018

1 reference

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

21 January 2018

1 reference

Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.

21 January 2018

1 reference

RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer.

21 January 2018

1 reference

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

21 January 2018

1 reference

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

21 January 2018

1 reference

Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.

21 January 2018

1 reference

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib

21 January 2018

1 reference

Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer

21 January 2018

1 reference

Prospective study to determine the volume of pleural fluid required to diagnose malignancy

21 January 2018

1 reference

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

21 January 2018

1 reference

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.

21 January 2018

1 reference

Epidermal growth factor receptor mutations in small cell lung cancer: a brief report.

21 January 2018

1 reference

Biomarkers in tumor angiogenesis and anti-angiogenic therapy

21 January 2018

1 reference

Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer

21 January 2018

1 reference

Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors

21 January 2018

1 reference

Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules

21 January 2018

1 reference

Angiogenesis in the treatment of non-small cell lung cancer

21 January 2018

1 reference

Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer

21 January 2018

1 reference

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control

21 January 2018

1 reference

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells

21 January 2018

1 reference

Vascular endothelial growth factor: the key mediator in pleural effusion formation

21 January 2018

1 reference

Pathophysiology of the pleura

21 January 2018

1 reference

Narrow band imaging applied to pleuroscopy for the assessment of vascular patterns of the pleura.

21 January 2018

1 reference

Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?

21 January 2018

1 reference

The matrix metalloproteinases and their inhibitors

21 January 2018

1 reference

Matrix metalloproteases and lung disease

21 January 2018

1 reference

MMP and TIMP expression pattern in pleural effusions of different origins

21 January 2018

1 reference

Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer

21 January 2018

1 reference

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea

21 January 2018

1 reference

Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer

21 January 2018

1 reference

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer

21 January 2018

1 reference

Cyclooxygenase as a target in lung cancer

21 January 2018

1 reference

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

21 January 2018

1 reference

Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group

21 January 2018

1 reference

Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis

21 January 2018

1 reference

Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338169

1 reference

26 August 2017

1 reference